VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Blood

Volumn 119, Issue 9, 2012, Pages 2135-2140

  Bellissimo, Daniel B ^a   Christopherson, Pamela A ^a   Flood, Veronica H ^b,c   Gill, Joan Cox ^a,b,c   Friedman, Kenneth D ^a   Haberichter, Sandra L ^a,b   Shapiro, Amy D ^d   Abshire, Thomas C ^a,b,c   Leissinger, Cindy ^e   Hoots, W Keith ^f   Lusher, Jeanne M ^g   Ragni, Margaret V ^h   Montgomery, Robert R ^a,b,c  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^d INDIANA HEMOPHILIA AND THROMBOSIS CENTER   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^h UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AFRICAN AMERICAN; ARTICLE; BLEEDING; CONTROLLED STUDY; ETHNIC OR RACIAL ASPECTS; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LABORATORY TEST; MUTATION RATE; MUTATIONAL ANALYSIS; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84857720362     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-10-384610     Document Type: Article

References (19)

1. Sadler JE, Budde U, Eikenboom JC, et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4(10):2103-2114. (Pubitemid 44403432)
2. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69(2):454-459. (Pubitemid 17022013)
3. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84(2):160-174. (Pubitemid 30601459)
4. Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 1993;69(2):177-184.
5. James PD, Notley C, Hegadorn C, et al. The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study. Blood. 2007;109(1):145-154. (Pubitemid 46053055)
6. Goodeve A, Eikenboom J, Castaman G, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood. 2007;109(1):112-121. (Pubitemid 46053051)
7. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet. 2008; 9:403-433.
8. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: national and state estimates. Am J Hematol. 2010;85(1):77-78.
9. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993;123(6):893-898. (Pubitemid 23353251)
10. Tosetto A, Rodeghiero F, Castaman G, et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost. 2006;4(4):766-773.
11. Haberichter SL, Shi Q, Montgomery RR. Regulated release of VWF and FVIII and the biologic implications. Pediatr Blood Cancer. 2006;46(5): 547-553.
12. Montgomery RR, Hathaway WE, Johnson J, Jacobson L, Muntean W. A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity. Blood. 1982; 60(1):201-207. (Pubitemid 12085940)
13. Haberichter SL, Balistreri M, Christopherson P, et al. Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival. Blood. 2006;108(10):3344-3351.
14. Flood VH, Gill JC, Morateck PA, et al. Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor. Blood. 2010;116(2):280- 286.
15. Peake IR, Goodeve AC. Genetic testing for von Willebrand disease: the case for. J Thromb Haemost. 2010;8(1):13-16.
16. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. 2nd Ed. London, United Kingdom: Academic Press; 2004.
17. O'Brien LA, James PD, Othman M, et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood. 2003; 102(2):549-557. (Pubitemid 36841974)
18. Kroner PA, Foster PA, Fahs SA, Montgomery RR. The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood. 1996;87(3):1013-1021. (Pubitemid 26043530)
19. Favaloro EJ. Genetic testing for von Willebrand disease: the case against. J Thromb Haemost. 2010;8(1):6-12.